Detalhe da pesquisa
1.
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305.
Clin Cancer Res
; 29(6): 1086-1101, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355054
2.
Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.
Oncotarget
; 9(33): 22960-22975, 2018 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29796165
3.
A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways.
Mol Cancer Ther
; 14(7): 1637-49, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25948294
4.
EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target.
Cancer Biol Ther
; 13(8): 630-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22555806